Thursday, September 25, 2014

Top 5 Promising Companies To Buy For 2014

Ka-ching! Dividend investors live for that sound. Each quarter thousands of companies hand over their excess cash to investors. But not all dividend stocks are equal. In fact, some are straight up risky while others are extremely promising. So how do you find an excellent dividend stock? It's simple. Look for companies with loads of cash. Case in point, Apple (NASDAQ: AAPL  ) -- a dividend investor's dream stock.

Two forms of cash
In business, cash comes in two forms: ongoing streams and accumulated hoards. Dividend investors want both.

Of the two forms of cash, the stream is the most important. Dividend investors should be able to rely on the company to throw off plenty of cash on an annual basis for years to come. Apple passes on this front with flying colors. In each of the last five years (and the trailing 12 months), Apple turned more than $0.20 of every dollar of sales into free cash flow, or FCF.

Source: Morningstar.

10 Best Canadian Stocks To Own Right Now: Comcast Corporation(CMCSA)

Comcast Corporation, together with its subsidiaries, provides entertainment, information, and communications products and services in the United States and internationally. Its Cable Communications segment provides video, high-speed Internet, and phone services to residential and business customers. As of June 30, 2011, its cable systems served approximately 22.5 million video customers, 17.5 million high-speed Internet customers, and 9.1 million phone customers. The company?s Cable Networks segment operates cable entertainment networks, such as USA Network, Syfy, E!, Bravo, Oxygen, Style, G4, Chiller, Sleuth, and Universal HD; news and information networks, including CNBC, MSNBC, and CNBC World; cable sports networks comprising Golf Channel and VERSUS; regional sports and news networks; international entertainment, and news and information networks, such as CNBC Europe, CNBC Asia, and Universal Networks International portfolio of networks; cable television production oper ations; and digital media properties consisting primarily of brand-aligned Websites and other Websites, such as DailyCandy, Fandango, and iVillage. Its Broadcast Television segment operates the U.S. broadcast networks, NBC and Telemundo; 10 NBC and 15 Telemundo owned local television stations; broadcast television productions; and related digital media properties. The company?s Filmed Entertainment segment operates Universal Pictures, which produces, acquires, markets, and distributes filmed entertainment and stage plays worldwide in various media formats for theatrical, home entertainment, television, and other distribution platforms. Its Theme Parks segment operates Universal Studios Hollywood park and Wet ?n Wild water park, as well as licenses intellectual properties and provides services to third parties that own and operate Universal Studios Japan and Universal Studios Singapore. Comcast Corporation was founded in 1963 and is based in Philadelphia, Pennsylvania.

Advisors' Opinion:
  • [By Anders Bylund]

    The muscle cars of Universal's Fast & Furious 6 aren't far behind, though. The sixth car-chase extravaganza in the series is set to deliver 27% of its box office take straight to studio owner Comcast's (NASDAQ: CMCSA  ) operating income. That's in spite of the second-thickest slice of profit-sharing deals with superstars like Vin Diesel and The Rock. Seems like you often get what you pay for in Hollywood. Big names pull in large audiences. In a business where nearly 100 cents out of every extra revenue dollar turns into operating profit, that's a pretty nice deal.

  • [By Bradley Seth, McNew]

    The park will be built in partnership with the Genting Group, a Malaysian entertainment company that owns and operates casinos and other entertainment services around the world. Genting is the same company that owns Resorts World Sentosa, one of only two casinos in neighboring Singapore. Genting is not new to these kinds of partnerships, either, as�it is the Resorts World in Singapore that houses Universal Studios Singapore. Universal Studios is owned by NBC Universal and parent company Comcast� (NASDAQ: CMCSA  ) . Theme park operations have been a lucrative segment for Comcast. The company made $270 million in total theme park income during Q3 2013 alone, up 7% from the same quarter last year.

Top 5 Promising Companies To Buy For 2014: Spirit Aerosystems Holdings Inc.(SPR)

Spirit AeroSystems Holdings, Inc., through its subsidiaries, designs and manufactures commercial aerostructures worldwide. It operates in three segments: Fuselage Systems, Propulsion Systems, and Wing Systems. The Fuselage Systems segment develops, produces, and markets forward, mid, and rear fuselage sections and systems primarily to aircraft original equipment manufacturers (OEMs), as well as offers related spares, and maintenance, repair, and overhaul (MRO) services. This segment also offers rotorcraft comprising forward cockpit and cabin for military aircrafts. The Propulsion Systems segment engages in the development, production, and marketing of struts/pylons; nacelles, including thrust reversers; and related engine structural components primarily to aircraft or engine OEMs, as well as provides related spares and MRO services. The Wing Systems segment develops, produces, and markets wings and wing components comprising flight control surfaces and other miscellaneous structural parts primarily to aircraft OEMs, as well as offers related spares and MRO services. This segment is also involved in designing, engineering, and manufacturing structural components for military aircrafts, including low observables that are radar absorbent and translucent materials; and radome new builds and refurbishment. It also provides other military services, such as fabrication, bonding, assembly, testing, tooling, processing, engineering analysis, and training. Spirit AeroSystems Holdings, Inc. serves large commercial airplanes, business and regional jets, and military/helicopter sectors of the aerostructures industry. The company was formerly known as Mid-Western Aircraft Systems Holdings, Inc. Spirit AeroSystems Holdings, Inc. is headquartered in Wichita, Kansas.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Spirit AeroSystems (NYSE: SPR) was up as well, gaining 6.74 percent to $32.48 as the company beat strongly on its top and bottom lines before the market opening Friday.

  • [By Inyoung Hwang]

    Axel Springer AG (SPR) declined 1.5 percent to 43.43 euros. Goldman Sachs Group Inc. cut its rating on Europe�� biggest newspaper publisher to sell from neutral, saying its valuation is the highest of the publishers it covers. Shares trade at 18.6 times earnings compared with 16.3 times for the DAX.

  • [By Michael Cintolo]

    Spirit AeroSystems (SPR) is a dominant supplier of aerostructures (fuselages, wing systems, etc.) to both Boeing and Airbus��n fact, it makes 70% of the airframe content for the Boeing 737, and is the largest aerostructure provider to Boeing's newer 787.

Top 5 Promising Companies To Buy For 2014: Cooper Companies Inc (COO)

The Cooper Companies, Inc., incorporated on March 4, 1980, is a global medical device company. The Company operates through two business units, CooperVision, Inc. and CooperSurgical, Inc. CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women.

CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision's products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness with a collection of spherical, toric and multifocal contact lenses. CooperVision's products are primarily manufactured at its facilities located in Hampshire, United Kingdom, Juana Diaz, Puerto Rico, and Scottsville, New York. CooperVision distributes products from West Henrietta, New York, Fareham, United Kingdom, Liege, Belgium, and various smaller international distribution facilities. Under the Biofinity brand, CooperVision has launched monthly silicone hydrogel spherical, toric and multifocal lens products. CooperVision has also launched two-week silicone hydrogel spherical and toric lens products under its Avaira brand. During the fiscal year ended October 31, 2013 (fiscal 2013), the Company launched MyDay, its single-use spherical silicone hydrogel lens, in Europe. CooperVision's Proclear line of spherical, toric and multifocal lenses are manufactured with omafilcon, a material that incorporates Phosphorylcholine (PC) Technology that helps enhance tissue-device compatibility.

CooperSurgical offers an array of products used in the care and treatment of women's health. The Company participates in the women's healthcare market through offering quality products, technologies and service to clinicians worldwide. CooperSurgical collaborates with clinicians to identify products and new technologies from dis! posable products to instruments and equipment. The result is a portfolio of products that aid in the delivery of improved clinical outcomes that healthcare professionals use routinely in the diagnosis and treatment of a wide spectrum of women's health issues.

The Company competes with Johnson & Johnson Vision Care, Inc., CIBA Vision, Bausch & Lomb Incorporated, Boston Scientific, Johnson & Johnson's Ethicon Endo-Surgery and Ethicon Women's Health and Urology companies, Gyrus ACMI and Covidien.

Advisors' Opinion:
  • [By Victor Selva]

    The company has a very attractive current ratio of 33.03% which is higher than its comps: Becton Dickinson & Co (BDX), Cardinal Health Inc (CAH), Cooper Companies (COO) and Luxottica Group S.p.A. (LUX).

  • [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

    Cooper Cos.(COO) said its revenue jumped more than 6% in its fiscal first quarter, though its profit still fell as result of higher costs and expenses.

Top 5 Promising Companies To Buy For 2014: Anacor Pharmaceuticals Inc. (ANAC)

Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company�s lead product candidates include tavaborole, an antifungal product candidate that is in Phase III clinical development for the treatment of onychomycosis; and AN2728, an anti-inflammatory product candidate, which completed Phase II clinical trials for the treatment of atopic dermatitis and psoriasis. It also develops AN5568, a Phase I human clinical trial product targeting human African trypanosomiasis; and other compounds to treat animal health indications. The company�s clinical pipeline also includes AN2718, a topical antifungal product candidate, which is in Phase I clinical trials for the treatment of onychomycosis and fungal infections of the skin; AN2898, a topical anti-inflammatory product candidate that completed the Phase IIa clinical trials for the treatment of atopic dermatitis and psoriasis; and AN3365, an antibiotic for the treatment of infections caused by Gram-negative bacteria. It has research, development, and collaboration agreements with GlaxoSmithKline LLC, Eli Lilly and Company, Medicis Pharmaceutical Corporation, and Medicines for Malaria Ventures. The company was formerly known as AnaMax, Inc. and changed its name to Anacor Pharmaceuticals, Inc. in October 2002. Anacor Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Palo Alto, California.

Advisors' Opinion:
  • [By Roberto Pedone]

     

    Anacor Pharmaceuticals (ANAC), a biopharmaceutical company, focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. This stock closed up 6.6% to $16.90 in Monday's trading session.

     

    Monday's Volume: 2.22 million

    Three-Month Average Volume: 425,667

    Volume % Change: 412%

     

    From a technical perspective, ANAC gapped sharply higher here back above both its 50-day moving average of $15.97 and its 200-day moving average of $16.50 with monster upside volume. This stock recently formed a double bottom chart pattern at $14.95 to $15.11. Since tagging that bottom, shares of ANAC have started to rip higher and move within range of triggering a big breakout trade. That trade will hit if ANAC manages to take out Monday's intraday high of $17.03 to $17.62 and then once it clears more near-term overhead resistance at $18.73 with high volume.

     

    Traders should now look for long-biased trades in ANAC as long as it's trending above Monday's intraday low of $16.15 and then once it sustains a move or close above those breakout levels with volume that hits near or above 425,667 shares. If that breakout kicks off soon, then ANAC will set up to re-test or possibly take out its next major overhead resistance levels at $21.27 to $23.07.

     

  • [By Jake L'Ecuyer]

    Top losers in the sector included Horizon Pharma (NASDAQ: HZNP), off 9.5 percent, and Anacor Pharmaceuticals (NASDAQ: ANAC), down 8.2 percent.

    Top Headline
    The Greenbrier Companies (NYSE: GBX) reported a 13% gain in its fiscal second-quarter earnings. Greenbrier's quarterly profit surged to $15.6 million, or $0.50 per share, versus a year-ago profit of $13.8 million, or $0.45 per share. Excluding one-time items, it earned $0.51 per share. Its revenue climbed 88% to $502.2 million. However, analysts were expecting earnings of $0.60 per share on revenue of $508.69 million.

  • [By Eric Volkman]

    Anacor Pharmaceuticals (NASDAQ: ANAC  ) is tapping the markets for a fresh infusion of capital. The company has put a price tag of $6.39 per share on its current underwritten public stock issue, in which it is aiming to unload nearly 3.13 million common shares. Additionally, the company's underwriters have been granted a 30-day purchase option for up to an additional 15% of the number of issued shares, in order to cover over-allotments.

  • [By Grace L. Williams]

    Honorable mentions go out to Coronado Biosciences (CNDO), after its CEO Harlan Weisman and Jay Lobell, a longtime director, joined forces and bought 20,000 shares for $152,100; and to Anacor Pharmaceuticals (ANAC) after CFO Geoffrey Parker bought 33,000 shares for $224,300. InsiderScore noted that Parker�� purchase was his largest to date and called it a ��ompelling positive event.��/p>

No comments:

Post a Comment